ROME GS System Study for diabetes glucose monitoring
Part of Hormones & metabolism clinical trials.
This study tests the ROME GS System, a glucose monitoring device that measures blood sugar levels. The system includes a sensor placed under the skin and a transmitter worn on the body. If you have diabetes and want to help evaluate a new way to track your blood sugar, this trial may be for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with diabetes for at least 1 year
- You have not had a severe low blood sugar episode (causing loss of consciousness or seizure) in the past 6 months
- You do not have a serious heart condition, recent heart attack or stroke, or very high blood pressure
- You are able to wear a sensor on your upper arm and are willing to follow the study procedures
- You are not pregnant, trying to become pregnant, or breastfeeding (if you can become pregnant)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new sensor system that tracks glucose levels continuously and can give a quick reading when you wave a device over it. It aims to see if it's safe and accurate for people with diabetes.
This study is testing a new implantable sensor (the HALO System) that measures glucose levels continuously in people with type 1 diabetes. It aims to see if the sensor is safe and works well, which could eventually lead to a more convenient way to track glucose without frequent fingersticks.
This trial tests if using a continuous glucose monitor (CGM) helps older adults with type 2 diabetes who are not on insulin to better control their blood sugar. The results will show if CGM is a helpful tool for managing diabetes without daily shots.
This study asks people with diabetes to wear three continuous glucose monitors (CGMs) for up to 15 days to compare how well they work. It tests a new CGM system called Argus 2.0, and you need to use your own smartphone for the study app.
This study tests if using a continuous glucose monitor (a small sensor that checks blood sugar without finger pricks) helps people with type 2 diabetes who are on insulin and have trouble accessing care. It's for patients in the New Orleans area with Medicaid, free care, or no insurance.
This trial studies how well a continuous glucose monitor (a sensor that tracks glucose) works for managing blood sugar in adults with type 1 or type 2 diabetes. You may need to wear sensors and have glucose levels adjusted during clinic visits to test safety and effectiveness.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.